Medical Properties Trust, Inc. (NYSE:MPW) – Stock analysts at Jefferies Group issued their Q1 2018 EPS estimates for Medical Properties Trust in a research note issued to investors on Thursday, Zacks Investment Research reports. Jefferies Group analyst O. Okusanya forecasts that the real estate investment trust will earn $0.34 per share for the quarter. Jefferies Group also issued estimates for Medical Properties Trust’s Q2 2018 earnings at $0.34 EPS, Q3 2018 earnings at $0.35 EPS, Q4 2018 earnings at $0.37 EPS, Q1 2019 earnings at $0.37 EPS, Q2 2019 earnings at $0.37 EPS, Q3 2019 earnings at $0.37 EPS and Q4 2019 earnings at $0.37 EPS.
Several other brokerages have also recently issued reports on MPW. Zacks Investment Research cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, January 3rd. JPMorgan Chase & Co. upgraded shares of Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 target price for the company in a report on Friday, December 15th. Robert W. Baird cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $15.00 to $13.00 in a report on Friday, January 5th. Finally, Deutsche Bank cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating and decreased their price target for the stock from $14.00 to $13.50 in a report on Wednesday, January 10th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $14.33.
Medical Properties Trust (NYSE MPW) traded down $0.04 during trading on Monday, reaching $12.91. 1,960,000 shares of the company’s stock traded hands, compared to its average volume of 2,610,000. The firm has a market cap of $4,710.00, a PE ratio of 15.74, a price-to-earnings-growth ratio of 2.63 and a beta of 0.82. The company has a debt-to-equity ratio of 1.28, a quick ratio of 2.06 and a current ratio of 2.06. Medical Properties Trust has a 52-week low of $11.82 and a 52-week high of $14.22.
Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, February 8th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.02. The business had revenue of $205.00 million for the quarter, compared to analysts’ expectations of $204.52 million. Medical Properties Trust had a net margin of 41.12% and a return on equity of 7.85%. The company’s revenue for the quarter was up 33.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.31 EPS.
A number of large investors have recently made changes to their positions in the business. Xact Kapitalforvaltning AB bought a new stake in Medical Properties Trust during the 4th quarter worth about $327,000. Sterling Capital Management LLC raised its holdings in Medical Properties Trust by 4.6% during the 4th quarter. Sterling Capital Management LLC now owns 1,338,154 shares of the real estate investment trust’s stock worth $18,440,000 after purchasing an additional 58,254 shares during the last quarter. MetLife Investment Advisors LLC bought a new stake in Medical Properties Trust during the 4th quarter worth about $3,175,000. Eii Capital Management Inc. bought a new stake in Medical Properties Trust during the 4th quarter worth about $687,000. Finally, Vident Investment Advisory LLC raised its holdings in Medical Properties Trust by 78.7% during the 4th quarter. Vident Investment Advisory LLC now owns 27,244 shares of the real estate investment trust’s stock worth $375,000 after purchasing an additional 12,000 shares during the last quarter. 80.91% of the stock is owned by hedge funds and other institutional investors.
In other Medical Properties Trust news, Chairman Edward K. Aldag, Jr. sold 489,971 shares of Medical Properties Trust stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $12.39, for a total transaction of $6,070,740.69. Following the sale, the chairman now owns 2,192,629 shares in the company, valued at $27,166,673.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.00% of the stock is owned by insiders.
The business also recently announced a quarterly dividend, which will be paid on Thursday, April 12th. Investors of record on Thursday, March 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, March 14th. This represents a $1.00 dividend on an annualized basis and a yield of 7.75%. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.24. Medical Properties Trust’s payout ratio is 117.07%.
COPYRIGHT VIOLATION NOTICE: This report was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://ledgergazette.com/2018/03/15/medical-properties-trust-inc-forecasted-to-earn-q1-2018-earnings-of-0-34-per-share-mpw.html.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.